Table 3.

Prognostic models for OS and PFS constructed with IPI and CD16−/CD16 + monocyte ratio.

	β	95% CI	p
Multi-COX for OS
IPI	3.821	1.822–8.012	0.000
CD16−M/CD16 + M	0.255	0.074–0.880	0.031
Multi-COX for PFS
IPI	2.380	1.430–3.961	0.001
CD16−M/CD16 + M	0.301	0.106–0.856	0.024